- Home
- FTEL vs SIGA Comparison
FTEL vs SIGA Comparison
Compare FTEL & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTEL
- SIGA
- Stock Information
- Founded
- FTEL 2007
- SIGA 1995
- Country
- FTEL Australia
- SIGA United States
- Employees
- FTEL N/A
- SIGA N/A
- Industry
- FTEL
- SIGA Biotechnology: Pharmaceutical Preparations
- Sector
- FTEL
- SIGA Health Care
- Exchange
- FTEL Nasdaq
- SIGA Nasdaq
- Market Cap
- FTEL 552.8M
- SIGA 551.0M
- IPO Year
- FTEL 2023
- SIGA 1997
- Fundamental
- Price
- FTEL $5.80
- SIGA $5.94
- Analyst Decision
- FTEL
- SIGA
- Analyst Count
- FTEL 0
- SIGA 0
- Target Price
- FTEL N/A
- SIGA N/A
- AVG Volume (30 Days)
- FTEL 341.4K
- SIGA 567.4K
- Earning Date
- FTEL 12-31-2024
- SIGA 11-07-2024
- Dividend Yield
- FTEL N/A
- SIGA 10.15%
- EPS Growth
- FTEL N/A
- SIGA N/A
- EPS
- FTEL N/A
- SIGA 1.20
- Revenue
- FTEL $4,466,775.00
- SIGA $173,731,386.00
- Revenue This Year
- FTEL N/A
- SIGA $16.79
- Revenue Next Year
- FTEL N/A
- SIGA $15.08
- P/E Ratio
- FTEL N/A
- SIGA $4.94
- Revenue Growth
- FTEL N/A
- SIGA 399.31
- 52 Week Low
- FTEL $0.88
- SIGA $4.26
- 52 Week High
- FTEL $49.50
- SIGA $12.83
- Technical
- Relative Strength Index (RSI)
- FTEL 30.69
- SIGA 38.74
- Support Level
- FTEL $4.62
- SIGA $5.62
- Resistance Level
- FTEL $49.50
- SIGA $6.23
- Average True Range (ATR)
- FTEL 7.18
- SIGA 0.43
- MACD
- FTEL -3.00
- SIGA -0.07
- Stochastic Oscillator
- FTEL 2.63
- SIGA 19.02
About FTEL Fitell Corporation
Fitell Corp engages in primary operations of selling gym and fitness equipment in Australia through its indirectly held wholly owned subsidiaries. It operates in two segments: online fitness equipment distribution and licensing business to service the large and growing boutique fitness sector of the broader health and fitness club industry. The majority fitness equipment business is conducted in Australia via its own e-commerce platform and, through third-party sites. Licensing service offers a turnkey solution for personal training studios and commercial gym chains.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.